Inter-society consensus for the use of inhaled corticosteroids in infants, children and adolescents with airway diseases

Background: In 2019, a multidisciplinary panel of experts from eight Italian scientific paediatric societies developed a consensus document for the use of inhaled corticosteroids in the management and prevention of the most common paediatric airways disorders. The aim is to provide healthcare providers with a multidisciplinary document including indications useful in the clinical practice. The consensus document was intended to be addressed to paediatricians who work in the Paediatric Divisions, the Primary Care Services and the Emergency Departments, as well as to Residents or PhD students, paediatric nurses and specialists or consultants in paediatric pulmonology, allergy, infectious diseases, and ear, nose, and throat medicine. Methods: Clinical questions identifying Population, Intervention(s), Comparison and Outcome(s) were addressed by methodologists and a general agreement on the topics and the strength of the recommendations (according to the GRADE system) was obtained following the Delphi method. The literature selection included secondary sources such as evidence-based guidelines and systematic reviews and was integrated with primary studies subsequently published. Results: The expert panel provided a number of recommendations on the use of inhaled corticosteroids in preschool wheezing, bronchial asthma, allergic and non-allergic rhinitis, acute and chronic rhinosinusitis, adenoid hypertrophy, laryngitis and laryngospasm. Conclusions: We provided a multidisciplinary update on the current recommendations for the management and prevention of the most common paediatric airways disorders requiring inhaled corticosteroids, in order to share useful indications, identify gaps in knowledge and drive future research

Change in pediatric health care spending and drug utilization during the Covid-19 pandemic

Objective: To evaluate how the restrictive measures implemented during the SARS-CoV-2 pandemic have influenced the incidence of the most common children’s diseases and the consumption of medications in 2020 compared to 2019. Methods: We involved all family pediatricians of the local health authority of Latina, from which we requested data of monthly visits in 2019 and 2020 for six common diseases disseminated through droplets and contact, and the territorial and integrative pharmaceutical unit of the area, from which we requested data of the net expenditure regarding the most commonly used drugs at pediatric age. Results: There was significant reduction in the incidence of the evaluated diseases and in the consumption of investigated drugs between 2019 and 2020 in the months when the restrictive measures were in place, with an attenuation of this effect during the months of the gradual loosening of those measures. Conclusion: Nonpharmaceutical intervention measures have caused changes in the diffusion of common pediatric diseases. We believe that the implementation of a reasonable containment strategy, even outside of the pandemic, could positively influence the epidemiology of infectious and allergic diseases in children, and healthcare system spending

La qualità dell'aria nelle scuole e rischi per malattie respiratorie e allergiche. Quadro conoscitivo sulla situazione italiana e strategie di prevenzione

Il lavoro è stato messo a punto dal Gruppo di Lavoro denominato “Progetto n.1 Programma di prevenzione per le scuole dei rischi indoor per malattie respiratorie e allergiche”(GARD-I n°)1, istituito nell’ambito della GARD Italia (GARD-I), nata in seguito all’adesione del Ministero della Salute alla GARD internazionale3. La GARD-I è un’alleanza nazionale volontaria che coinvolge i principali stakeholder delle malattie respiratorie (società scientifiche, associazioni dei pazienti, università ed Enti di ricerca), finalizzata all’elaborazione ed applicazione di una strategia globale ed integrata per ridurre incidenza, morbosità e mortalità delle malattie respiratorie croniche nel lungo periodo. Lo scopo di questo documento è quello di fornire un quadro conoscitivo sulla qualità dell’aria nelle scuole in Italia ed i relativi rischi per la salute respiratoria degli studenti e fornire delle evidenze rispetto ai vantaggi che può offrire una strategia di promozione della salute nelle scuole. Il documento mostra come le problematiche inerenti la promozione della salute nelle scuole siano legate ad un approccio globale e intersettoriale che comprende le politiche per una scuola sana che comprendono anche l’ambiente degli istituti scolastici. Il documento illustra in chiave sintetica i principali passi da compiere per costruire azioni efficaci nel ridurre i rischi indoor negli ambienti scolastici e garantire il benessere degli studenti, migliorando anche i risultati in termini di rendimento scolastico

Correction: Inter-society consensus for the use of inhaled corticosteroids in infants, children and adolescents with airway diseases (Italian Journal of Pediatrics, (2021), 47, 1, (97), 10.1186/s13052-021-01013-8)

The original article contained an incorrect institution for Affiliation #22 which has since been corrected

Inter-society consensus for the use of inhaled corticosteroids in infants, children and adolescents with airway diseases

none76noneDuse M.a,Santamaria F.,Verga M.C.,Bergamini M.,Simeone G.,Leonardi L.,Tezza G.,Bianchi A.,Capuano A.,Cardinale F.,Cerimoniale G.,Landi M.,Malventano M.,Tosca M.,Varricchio A.,Zicari A.M.,Alfaro C.,Barberi S.,Becherucci P.,Bernardini R.,Biasci P.,Caffarelli C.,Caldarelli V.,Capristo C.,Castronuovo S.,Chiappini E., ,Cutrera R.,De Castro G.,De Franciscis L.,Decimo F.,Iacono I.D.,Diaferio L.,Di Cicco M.E.,Di Mauro C.,Di Mauro C.,Di Mauro D.,Di Mauro F.,Di Mauro G.,Doria M.,Falsaperla R.,Ferraro V.,Fanos V.,Galli E.,Ghiglioni D.G.,Indinnimeo L.,Kantar A.,Lamborghini A.,Licari A.,Lubrano R.,Luciani S.,Macrì F.,Marseglia G.,Martelli A.G.,Masini L.,Midulla F.,Minasi D.,Miniello V.L.,del Giudice M.M.,Morandini S.R.,Nardini G.,Nocerino A.,Novembre E.,Pajno G.B.,Paravati F.,Piacentini G.,Piersantelli C.,Pozzobon G.,Ricci G.,Spanevello V.,Turra R.,Zanconato S.,Borrelli M.,Villani A.,Corsello G.,Di Mauro G.,Peroni D.Duse M., A; Santamaria, F.; Verga, M. C.; Bergamini, M.; Simeone, G.; Leonardi, L.; Tezza, G.; Bianchi, A.; Capuano, A.; Cardinale, F.; Cerimoniale, G.; Landi, M.; Malventano, M.; Tosca, M.; Varricchio, A.; Zicari, A. M.; Alfaro, C.; Barberi, S.; Becherucci, P.; Bernardini, R.; Biasci, P.; Caffarelli, C.; Caldarelli, V.; Capristo, C.; Castronuovo, S.; Chiappini, E.; Cutrera, R.; De Castro, G.; De Franciscis, L.; Decimo, F.; Iacono, I. D.; Diaferio, L.; Di Cicco, M. E.; Di Mauro, C.; Di Mauro, C.; Di Mauro, D.; Di Mauro, F.; Di Mauro, G.; Doria, M.; Falsaperla, R.; Ferraro, V.; Fanos, V.; Galli, E.; Ghiglioni, D. G.; Indinnimeo, L.; Kantar, A.; Lamborghini, A.; Licari, A.; Lubrano, R.; Luciani, S.; Macrì, F.; Marseglia, G.; Martelli, A. G.; Masini, L.; Midulla, F.; Minasi, D.; Miniello, V. L.; del Giudice, M. M.; Morandini, S. R.; Nardini, G.; Nocerino, A.; Novembre, E.; Pajno, G. B.; Paravati, F.; Piacentini, G.; Piersantelli, C.; Pozzobon, G.; Ricci, G.; Spanevello, V.; Turra, R.; Zanconato, S.; Borrelli, M.; Villani, A.; Corsello, G.; Di Mauro, G.; Peroni, D

Inter-society consensus for the use of inhaled corticosteroids in infants, children and adolescents with airway diseases

Background: In 2019, a multidisciplinary panel of experts from eight Italian scientific paediatric societies developed a consensus document for the use of inhaled corticosteroids in the management and prevention of the most common paediatric airways disorders. The aim is to provide healthcare providers with a multidisciplinary document including indications useful in the clinical practice. The consensus document was intended to be addressed to paediatricians who work in the Paediatric Divisions, the Primary Care Services and the Emergency Departments, as well as to Residents or PhD students, paediatric nurses and specialists or consultants in paediatric pulmonology, allergy, infectious diseases, and ear, nose, and throat medicine. Methods: Clinical questions identifying Population, Intervention(s), Comparison and Outcome(s) were addressed by methodologists and a general agreement on the topics and the strength of the recommendations (according to the GRADE system) was obtained following the Delphi method. The literature selection included secondary sources such as evidence-based guidelines and systematic reviews and was integrated with primary studies subsequently published. Results: The expert panel provided a number of recommendations on the use of inhaled corticosteroids in preschool wheezing, bronchial asthma, allergic and non-allergic rhinitis, acute and chronic rhinosinusitis, adenoid hypertrophy, laryngitis and laryngospasm. Conclusions: We provided a multidisciplinary update on the current recommendations for the management and prevention of the most common paediatric airways disorders requiring inhaled corticosteroids, in order to share useful indications, identify gaps in knowledge and drive future research